Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Lauranne A.A.P. Derikx, Loes H.C. Nissen, Joost P.H. Drenth, Carla M. van Herpen, Wietske Kievit, Rob H.A. Verhoeven, Peter F.A. Mulders, Christina A. Hulsbergen-van de Kaa, Marye J. Boers-Sonderen, Tim R.A. van den Heuvel, Marieke Pierik, Iris D. Nagtegaal, Frank Hoentjen, on behalf of the Dutch Initiative on Crohn and Colitis (ICC), PALGA group and IBD/RCC group
Published Oct 5, 2015 · Vol. 6, No. 35 · pp. 38336-38347
Daren Low, Renuka Subramaniam, Li Lin, Tomoki Aomatsu, Atsushi Mizoguchi, Aylwin Ng, Arianna K. DeGruttola, Chun Geun Lee, Jack A. Elias, Akira Andoh, Mari Mino-Kenudson, Emiko Mizoguchi
Published Sep 28, 2015 · Vol. 6, No. 34 · pp. 36535-36550